Non-Current Assets
Equity securities
Edwards Lifesciences Equity securities increased by 191.5% to $20.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 269.6%, from $5.60M to $20.70M. Over 5 years (FY 2020 to FY 2025), Equity securities shows a downward trend with a -24.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ4 2024
Last reportedQ1 2026
How to read this metric
An increase reflects positive market performance of the underlying investments or additional capital deployment into equities.
Detailed definition
This represents the fair market value of the company's investment portfolio consisting of equity securities in other ent...
Peer comparison
Standard for companies with large corporate venture arms or significant treasury investment portfolios.
Metric ID:
ins_equity_securitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.60M | $73.60M | $84.10M | $84.40M | $85.30M | $87.40M | $86.90M | $86.90M | $86.90M | $86.90M | $87.60M | $88.70M | $89.60M | $7.40M | $5.50M | $5.60M | $5.10M | $6.10M | $7.10M | $20.70M |
| QoQ Change | — | +0.0% | +14.3% | +0.4% | +1.1% | +2.5% | -0.6% | +0.0% | +0.0% | +0.0% | +0.8% | +1.3% | +1.0% | -91.7% | -25.7% | +1.8% | -8.9% | +19.6% | +16.4% | +191.5% |
| YoY Change | — | — | — | — | +15.9% | +18.8% | +3.3% | +3.0% | +1.9% | -0.6% | +0.8% | +2.1% | +3.1% | -91.5% | -93.7% | -93.7% | -94.3% | -17.6% | +29.1% | +269.6% |
Range$5.10M – $89.60M
CAGR-23.4%
Avg YoY Growth-2.7%
Median YoY Growth+2.0%
Current Streak3 quarters growth
Equity securities at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's equity securities?
- Edwards Lifesciences (EW) reported equity securities of $20.70M in Q1 2026.
- How has Edwards Lifesciences's equity securities changed year-over-year?
- Edwards Lifesciences's equity securities increased by 269.6% year-over-year, from $5.60M to $20.70M.
- What is the long-term trend for Edwards Lifesciences's equity securities?
- Over 5 years (2020 to 2025), Edwards Lifesciences's equity securities has grown at a -24.7% compound annual growth rate (CAGR), from $29.40M to $7.10M.
- What does equity securities mean?
- The current market value of the company's stock investments in other businesses.